Rubicon Research

Rubicon Research Equity

The The Equity of Rubicon Research (RUBICON.NS) as of Oct 18, 2026 is 12.89 B INR. In the previous year, The Equity was 3.85 B INR — a change of 234.76% (higher).

Equity

12.89 BINR

YoY

234.76%

Last updated:

In 2026, Rubicon Research's equity was 12.89 B INR, a 234.76% increase from the 3.85 B INR equity in the previous year.

The Rubicon Research Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2023
2.86 B INR
Jan 1, 2024
3.85 B INR
Jan 1, 2026
12.89 B INR
The Rubicon Research Equity history
YEAREquityYoY
12.89 BINR+234.76%
3.85 BINR+34.44%
2.86 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Rubicon Research Stock analysis

What does Rubicon Research do? Rubicon Research Ltd is a company based in Thane, India, with an employee count of 1141. It operates in the manufacturing and export of pharmaceutical formulations across various dosage forms and therapeutic areas. The company's portfolio includes oral solids, oral liquids, nasal, and topical dosage forms. Its services encompass intellectual property evaluation, product design, formulation and analytical research and development, technology transfer, dossier compilation, regulatory support, and clinical trials supplies. The company's products cover therapeutic areas such as Analgesics/Pain Management, CVS, CNS, Hypokalemia, Skeletal Muscle Relaxants, NRT, Gastrointestinal, Metabolic, Immunosuppressant, and others. Additional therapeutic areas include Antipyretic, Hormonal Products, Diuretic, Antimuscarinics, Oral Rehydration Therapy, Over the Counter products, and Respiratory. Rubicon Research Ltd is scheduled to go public with an IPO on October 16, 2025. The company's website is https://www.rubicon.co.in/. Rubicon Research is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Rubicon Research's Equity

Rubicon Research's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Rubicon Research's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Rubicon Research's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Rubicon Research's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Rubicon Research’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Rubicon Research stock

The Equity of Rubicon Research is 12.89 B INR in 2026.

The Equity of Rubicon Research changed from 3.85 B INR to 12.89 B INR, representing a 234.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Rubicon Research since 2006 – with annual values, charts, and detailed analysis.

The Equity's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Rubicon Research historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Rubicon Research

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Rubicon Research